Medicine
Ropinirole 0.25 mg tablet
Ropinirole 0.25 mg tablet is a generic prescription medicine for oral use, made by 17 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature 20°-25°C (68°-77°F).
Key facts
- Active ingredient (INN)
- Ropinirole
- Brand
- Sold under the generic name
- Strength
- 0.25 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 10 blister pack and 39 more
- Manufacturers
- Glenmark PharmaceuticalsIndiaAlembic PharmaceuticalsIndiaAccord HealthcareIndiaBryant Ranch PrepackAsclemedSolco HealthcareA-S Medication SolutionsDirect_RxProficient RxAmerican Health Packaging17 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature 20°-25°C (68°-77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N04BC04 Ropinirole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 February 2010
- Identifiers
- RxCUI 312845, 312846, 312847 +4DailyMed set ID 48a63d7e-c0af-4b09-863c-2af7beb2e80f, 7734ef0b-584f-42dd-a8b5-adbdf4e4df93, e699a31a-25fc-554b-e053-2a95a90a843a +21NDC 0615-8188, 43547-268, 50268-741 +21Application ANDA090429, ANDA078110, ANDA090135 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 17 labelers. The register lists 42 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 46708-030-31 | Alembic PharmaceuticalsIndia | 12 September 2013 |
| 100 tablet, film coated in 1 bottle | 62332-030-31 | Alembic PharmaceuticalsIndia | 29 January 2016 |
| 100 tablet, film coated in 1 bottle | 16729-232-01 | Accord HealthcareIndia | 17 October 2018 |
| 100 tablet, film coated in 1 bottle | 68462-253-01 | Glenmark PharmaceuticalsIndia | 25 February 2010 |
| 1000 tablet, film coated in 1 bottle | 68462-253-10 | Glenmark PharmaceuticalsIndia | 25 February 2010 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 68462-253-11 | Glenmark PharmaceuticalsIndia | 25 February 2010 |
| 100 tablet, film coated in 1 bottle, plastic | 43547-268-10 | Solco Healthcare | 20 September 2011 |
| 500 tablet, film coated in 1 bottle, plastic | 43547-268-50 | Solco Healthcare | 20 September 2011 |
| 100 tablet, film coated in 1 bottle, plastic | 43547-595-10 | Solco Healthcare | 20 September 2011 |
| 500 tablet, film coated in 1 bottle, plastic | 43547-595-50 | Solco Healthcare | 20 September 2011 |
| 100 tablet, film coated in 1 bottle, plastic | 69452-356-20 | Bionpharma | 15 September 2022 |
| 100 tablet, film coated in 1 bottle | 50090-1330-0 | A-S Medication Solutions | 28 November 2014 |
| 100 tablet, film coated in 1 bottle | 50090-1822-0 | A-S Medication Solutions | 12 May 2015 |
| 100 tablet, film coated in 1 bottle | 50090-4803-0 | A-S Medication Solutions | 20 December 2019 |
| 30 tablet, film coated in 1 bottle | 71335-0587-1 | Bryant Ranch Prepack | 9 December 2016 |
| 60 tablet, film coated in 1 bottle | 71335-0587-2 | Bryant Ranch Prepack | 9 December 2016 |
| 28 tablet, film coated in 1 bottle | 71335-0587-3 | Bryant Ranch Prepack | 9 December 2016 |
| 100 tablet, film coated in 1 bottle | 71335-0587-4 | Bryant Ranch Prepack | 9 December 2016 |
| 30 tablet, film coated in 1 bottle | 71335-1231-1 | Bryant Ranch Prepack | 24 May 2019 |
| 60 tablet, film coated in 1 bottle | 71335-1231-2 | Bryant Ranch Prepack | 31 October 2024 |
| 28 tablet, film coated in 1 bottle | 71335-1231-3 | Bryant Ranch Prepack | 31 October 2024 |
| 100 tablet, film coated in 1 bottle | 71335-1231-4 | Bryant Ranch Prepack | 31 October 2024 |
| 30 tablet, film coated in 1 bottle | 71335-2793-1 | Bryant Ranch Prepack | 11 March 2026 |
| 60 tablet, film coated in 1 bottle | 71335-2793-2 | Bryant Ranch Prepack | 11 March 2026 |
| 28 tablet, film coated in 1 bottle | 71335-2793-3 | Bryant Ranch Prepack | 11 March 2026 |
| 100 tablet, film coated in 1 bottle | 71335-2793-4 | Bryant Ranch Prepack | 11 March 2026 |
| 30 tablet, film coated in 1 bottle | 72189-364-30 | Direct_Rx | 21 June 2022 |
| 30 tablet, film coated in 1 bottle | 72189-416-30 | Direct_Rx | 1 February 2023 |
| 100 blister pack in 1 box, unit-dose / 1 tablet, film coated in 1 blister pack | 60687-577-01 | American Health Packaging | 10 June 2021 |
| 100 tablet, film coated in 1 bottle, plastic | 87063-198-01 | Asclemed | 7 May 2026 |
| 30 tablet, film coated in 1 bottle, plastic | 87063-198-30 | Asclemed | 7 May 2026 |
| 60 tablet, film coated in 1 bottle, plastic | 87063-198-60 | Asclemed | 7 May 2026 |
| 90 tablet, film coated in 1 bottle, plastic | 87063-198-90 | Asclemed | 7 May 2026 |
| 50 blister pack in 1 box / 1 tablet, film coated in 1 blister pack | 50268-741-15 | AvPAK | 19 August 2022 |
| 10 blister pack in 1 bag / 1 tablet, film coated in 1 blister pack | 55154-7888-0 | Cardinal Health | 1 October 2014 |
| 100 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 0904-6373-61 | Major Pharmaceuticals | 1 October 2014 |
| 100 tablet, film coated in 1 bottle | 10135-673-01 | Marlex Pharmaceuticals | 15 March 2019 |
| 90 tablet, film coated in 1 bottle, plastic | 51655-360-26 | Northwind Health | 28 May 2020 |
| 30 tablet, film coated in 1 bottle, plastic | 71205-825-30 | Proficient Rx | 11 August 2023 |
| 60 tablet, film coated in 1 bottle, plastic | 71205-825-60 | Proficient Rx | 11 August 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 19 September 1997 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Ropinirole
Clinical summary
Ropinirole is a nonergot dopamine agonist indicated for the treatment of Parkinson’s disease (PD) and moderate-to-severe primary Restless Legs Syndrome (RLS), among other approved uses. It is available as tablets and extended-release tablets for oral use. MedsAcross supplies Ropinirole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RopiniroleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ROPINIROLE prescribing information (Alembic Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Ropinirole 0.25 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.